2015
DOI: 10.1038/bonekey.2015.57
|View full text |Cite
|
Sign up to set email alerts
|

Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors

Abstract: Bone marrow is a heterogeneous organ containing diverse cell types, and it is a preferred metastatic site for several solid tumors such as breast and prostate cancer. Recently, it has been shown that bone metastatic cancer cells interact with the bone marrow microenvironment to survive and grow, and thus this microenvironment is referred to as the 'metastatic niche'. Once cancer cells spread to distant organs such as bone, the prognosis for the patient is generally poor. There is an urgent need to establish a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
72
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(72 citation statements)
references
References 73 publications
0
72
0
Order By: Relevance
“…Unexpectedly, the transcriptional landscape of diagnostic DTCs resembled that of relapse DTCs to a large extent, although these patients had experienced multimodal treatment. This observation may be explained by the protective BM niche, just as it has been shown that the BM microenvironment promotes their survival, dormancy, growth and drug resistance . Remarkably, we found that the genes which were differentially expressed between diagnostic and relapse DTCs show a positional enrichment on chromosome 19, with five tumor suppressor genes being downregulated in relapse DTCs.…”
Section: Discussionmentioning
confidence: 63%
“…Unexpectedly, the transcriptional landscape of diagnostic DTCs resembled that of relapse DTCs to a large extent, although these patients had experienced multimodal treatment. This observation may be explained by the protective BM niche, just as it has been shown that the BM microenvironment promotes their survival, dormancy, growth and drug resistance . Remarkably, we found that the genes which were differentially expressed between diagnostic and relapse DTCs show a positional enrichment on chromosome 19, with five tumor suppressor genes being downregulated in relapse DTCs.…”
Section: Discussionmentioning
confidence: 63%
“…Bone metastases most commonly originate from breast and prostate tumors, and are generally associated with poor prognoses (Shiozawa et al, 2015). Osteotropic metastases can be characterized as osteolytic (stimulates bone destruction) or osteoblastic (stimulates bone formation), both of which are detrimental to the patient.…”
Section: Bone Metastases: Undercover Agents To Destroy and Invade Bonementioning
confidence: 99%
“…Once within the circulatory system, the neoplastic cells may invade the bone marrow and actively act in this microenvironment resulting in the development of metastatic neoplasia. The tumor growth is stimulated both by the activation of osteoclasts and by the release of growth factors within the bone marrow, and is inhibited by osseous formation and decreased osteoclastogenesis 13 , 18. It seems that the tumor gastric cells induce the differentiation and activation of the osteoclasts by the production of cytokines and via the RANK/RANKL system 19.…”
Section: Discussionmentioning
confidence: 99%